Sfoglia per AUTORE
BOTTA M
Collezione ASL Alessandria

  

Items : 8

Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey. in British journal of cancer / Br J Cancer. 2014 Jul 15;111(2):220-6. doi: 10.1038/bjc.2014.312. Epub 2014 Jun 10.

2014
ASL Alessandria

Giordano L; Santoro A; Botta M; Favaretto AG; Beretta GD; Piccolini E; Dipietrantonj C; Bruzzone A; Degiovanni D; Simonelli M; Ripa C; Pasello G; Mencoboni M; Zucali PA; Grosso F; Ceresoli GL;

Activity of eribulin on skin metastases in breast cancer patients in Journal of Clinical Oncology

2013
ASL Alessandria

La Verde NM; Moretti A; Gamucci T; Borgonovo K; Botta M; Salesi N; Zuradelli M; Pavese I; Barbieri E; Cretella E; Saladino T; Varese P; Addamo G; Ciccarese M; Rispoli AI; Pellegrino A; Mentuccia L; Piva S; Farina G; Di Maio M;

Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM). in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2008 Feb;19(2):370-3. doi: 10.1093/annonc/mdm501. Epub 2007 Dec 20.

2008
ASL Alessandria

Castagneto B; Botta M; Aitini E; Spigno F; Degiovanni D; Alabiso O; Serra M; Muzio A; Carbone R; Buosi R; Galbusera V; Piccolini E; Giaretto L; Rebella L; Mencoboni M;

Molecular effects of vandetanib (zactima) in malignant pleural mesothelioma. An in-vitro study in Annals of Oncology

2008
ASL Alessandria

Betta P; Arnolfo E; Libener R; Salvio M; Botta M; Piccolini E; Orecchia S;

Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study. in American journal of clinical oncology / Am J Clin Oncol. 2005 Jun;28(3):223-6. doi: 10.1097/01.coc.0000144852.75613.56.

2005
ASL Torino 4
ASL Alessandria

Bretti S; Muzio A; Dongiovanni D; Zai S; Castagneto B; Numico G; Botta M; Sinaccio G;

Single-agent gemcitabine in previously untreated elderly patients with advanced bladder carcinoma: response to treatment and correlation with the comprehensive geriatric assessment. in Oncology / Oncology. 2004;67(1):27-32. doi: 10.1159/000080282.

2004
ASL Alessandria

Mencoboni M; Ferraris V; Botta M; Repetto L; Scaltriti L; Zai S; Marenco D; Bertetto O; Castagneto B;

Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2001 Feb-Mar;31(2-3):303-10. doi: 10.1016/s0169-5002(00)00192-6.

2001
ASL Alessandria

Zai S; Mutti L; Lazzaro A; Castagneto B; Fumagalli L; Valsuani G; Botta M; Ridolfi R; Piccolini E; Ardizzoni A;

Mortality from respiratory and digestive cancers among asbestos cement workers in Italy. in Cancer detection and prevention / Cancer Detect Prev. 1991;15(6):445-7.

1991
ASL Alessandria

Paglieri P; Cocito V; DeGiovanni D; Bertolone GP; Castagneto B; Magnani C; Terracini B; Botta M;